U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Search Results

Dextrose 25% Injection
Status: Currently in Shortage
»Date first posted: 02/07/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Hospira, Inc., a Pfizer Company (Reverified 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.5 g/10 mL (250 mg/mL), plastic syringe, 10 per bundle (NDC 0409-1775-10) Limited Supply Available. Next Delivery: July 2022; Estimated Recovery: October 2022

Pfizer Customer Letter dated March 4, 2022.

Demand increase for the drug
Back to Top